Planet Labs PBC filings document an Earth-observation company that provides satellite imagery, geospatial data, and related software solutions. The company’s 8-K reports include operating results, Regulation FD disclosures, material agreements, and other events tied to its commercial and government satellite-data business.
Recent filings also describe capital-structure matters involving Class A common stock, Class B common stock, earnout share issuances, and public warrants originally issued with IPO units. The record includes warrant redemption disclosures and a Form 25 covering removal of the redeemable warrants from NYSE listing and registration.
Planet Labs PBC (PL) received a notice that ULYSSES TRUST 02021.1 U/ADTD 02/26/2021 intends to sell common stock under Rule 144. The trust lists 52,240 common shares to be sold through Morgan Stanley Smith Barney LLC. Over the prior three months, the trust sold 89,593 shares for $2,322,223.68 in 10b5-1 transactions.
Planet Labs PBC (symbol PL) has a notice of proposed sale of restricted securities under Rule 144 filed on behalf of the Johnson Joint Revocable Trust. The trust indicates an intention to sell up to 55,663 shares of common stock, with an approximate aggregate market value of $891,721.26, through Morgan Stanley Smith Barney LLC on the NYSE, referencing a date of September 17, 2026.
The notice also lists prior Rule 10b5-1 sales by the Johnson Joint Revocable Trust of 110,028 shares of Planet Labs common stock on July 23, 2026 for proceeds of $2,429,462.25. The securities to be sold are associated with Restricted Stock Units originally acquired from the issuer.
Planet Labs PBC (PL) reported strong top-line growth for the quarter ended July 31, 2026, with revenue of $116.1 million versus $73.4 million a year earlier, and six‑month revenue of $210.2 million versus $139.7 million. Growth was broad-based across regions and was led by Defense & Intelligence customers.
Despite higher operating expenses, quarterly net loss narrowed to $9.4 million from $22.6 million, though the six‑month net loss widened to $148.2 million, driven largely by a $106.5 million non‑cash loss from warrant revaluation earlier in the year. Planet ended the period with $423.6 million in cash and restricted cash, $450.3 million in short‑term investments, and reported remaining performance obligations of $753.1 million. The company strengthened its balance sheet via warrant exercises and an at‑the‑market equity program and has $460.0 million of 0.50% convertible 2030 Notes outstanding, which became convertible for a limited window after the stock price met the specified trigger.
Planet Labs PBC (PL) reported a strong second quarter of fiscal 2027, with record revenue of $116.1 million, up 58% year over year, and 98% of annual contract value classified as recurring. GAAP net loss narrowed to $9.4 million, while non-GAAP results showed net income of $8.3 million and adjusted EBITDA profit of $13.9 million, more than double the prior-year quarter.
Cash, cash equivalents and short-term investments reached $865.4 million, helped by approximately $120 million of at-the-market stock sales at an average net price of $31.95 per share. Remaining performance obligations were $753.1 million and backlog was $814.9 million, with roughly half expected to be recognized within 12 months.
For Q3 FY2027, Planet expects revenue of $101–$105 million, non-GAAP gross margin of 56–58%, and an adjusted EBITDA loss of $(6)–$(1) million. For the full fiscal year 2027, it guides to revenue of $430–$441 million, non-GAAP gross margin of 55–57%, adjusted EBITDA profit of $3–$10 million, and capital expenditures of $100–$115 million.
Planet Labs PBC director and Co‑Founder Chief Strategy Officer Robert H. Schingler reported a bona fide gift of 55,000 shares of Class A Common Stock on August 5, 2026, from Ulysses Trust 02021.1, with no value received. Following the gift, the trust holds 170,171 shares indirectly.
Schingler also reports 825,541 shares held directly, including 744,984 RSUs that vest in equal quarterly installments. The transactions were affirmed under a Rule 10b5‑1 trading plan.
BlackRock, Inc. filed an amended ownership report for Planet Labs PBC Class A stock. BlackRock reports beneficial ownership of 14,179,036 shares, representing 4.3% of the class. It holds 13,626,744 shares with sole voting power and all 14,179,036 shares with sole dispositive power, with no shared voting or dispositive power.
Various underlying clients have rights to dividends or sale proceeds from these shares, but no single client holds more than five percent of Planet Labs’ outstanding common shares. The filing is signed by Managing Director Spencer Fleming on July 29, 2026.
Planet Labs PBC President & CFO Ashley F. Johnson reported several equity transactions on July 23, 2026. She transferred 70,767 Class A shares from direct ownership to the Johnson Joint Revocable Trust, then sold 75,035 directly held shares and 34,993 trust-held shares in open market or private transactions at a weighted average $22.0804 per share, under a Rule 10b5-1 trading plan adopted on April 23, 2026. A related footnote states she continues to hold 1,132,122 RSUs that vest quarterly.
Planet Labs PBC director Kristen Robinson reported an open-market sale of 37,107 shares of Class A Common Stock at a weighted-average price of $25.0529 per share, executed under a Rule 10b5-1 trading plan. Additional “J” code entries record a non-priced transfer of 37,107 shares from her direct holdings to The Gary and Kristen Robinson Trust, a revocable trust where she and her spouse serve as trustees. After these transactions, she holds 222,897 shares indirectly through the trust and 6,479 shares directly.